Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.
Clinical trial NCT05763875 · COMPLETED
Trial details
- NCT number
- NCT05763875
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2024-06-20
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.